Fairvalue-Calculator Fairvalue-Calculator
EN DE

DC Healthcare Holdings (0283) Fair Value & Analysis

Healthcare · MY · Market cap 105M MYR

Price0.1050 MYR
Fair Value0.0300 MYR
Upside-71.4%
Quality95/100
Evidence: High Range 0.0300 MYR – 0.0500 MYR

Fair value as of: Jun 26, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

DC Healthcare Holdings (0283) currently trades at 0.1050 MYR, while our model-based Fair Value estimate is 0.0300 MYR — implying the stock looks roughly 71.4% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

DC Healthcare Holdings Berhad, an investment holding company, provides aesthetic medical services specializing in non-invasive and minimally invasive procedures in Malaysia. The company offers aesthetic services, including facial and skin treatments, facial sculpting, body contouring, and hair growth and removal; and general medical consultation services comprising annual health check-ups and skin disease treatment, as well as sells skincare products to under the newB brand name through online stores. The company was founded in 2016 and is headquartered in Kuala Puchong, Malaysia. DC Healthcare Holdings Berhad is a subsidiary of DC Healthcare Group Sdn Berhad.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is DC Healthcare Holdings (0283) undervalued?
As of Jun 26, 2026, our model estimates a fair value of 0.0300 MYR versus a price of 0.1050 MYR — about −71% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 0283?
Our 21-model fair value for DC Healthcare Holdings is 0.0300 MYR (as of Jun 26, 2026), built from audited fundamentals. The current price is 0.1050 MYR.
What is the quality score of 0283?
DC Healthcare Holdings has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.